Protalix reports Q3 2026 results, reaffirms revenue guidance, RELEASE gout study enrollingNov 10Quarterly updateProtalix BioTherapeutics, Inc.
Protalix reports Q2 2026 results, reaffirms PRX-115 gout trial timeline and 2026 revenue guidanceAug 12Quarterly updateProtalix BioTherapeutics, Inc.